November 2022

Editorial Board
Published in issue: November 2022
i-ii

Contents
Published in issue: November 2022
iii-v

Opinion: Open Science

Treatment Intensification for Low-risk Metastatic Hormone-sensitive Prostate Cancer: The Time Is Now
• Rana R. McKay
Published online: September 28, 2022
p41-43
Diagnosis of Clinically Significant Prostate Cancer Diagnosis Without Histological Proof in the Prostate-specific Membrane Antigen Era: The Jury Is Still Out
• Mike Wenzel,
• Benedikt Hoeh,
• Philipp Mandel,
• Felix KH Chun
Published online: October 01, 2022
p50-51

Brief Correspondence

Intravesical Ty21a Treatment of Non–muscle-invasive Bladder Cancer Shows a Good Safety Profile
• Ilaria Lucca,
• Laurent Derré,
• Valérie Cesson,
• ...
• Beat Roth,
• Patrice Jichlinski,
• Denise Nardelli-Haefliger
Published online: October 03, 2022
p55-58

Open Horizon

Hormonal Intensification Should Start at the Low-risk Stage in Metastatic Prostate Cancer
• Seyed Behzad Jazayeri,
• Lauren Folgosa Cooley,
• Abhishek Srivastava,
• Neal Shore
Published online: September 28, 2022
p38-40

Reviews

Role of Pediatric Ureteral Access Sheath and Outcomes Related to Flexible Ureteroscopy and Laser Stone Fragmentation: A Systematic Review of Literature
• Francesco Ripa,
• Theodoros Tokas,
• Stephen Griffin,
• Stefania Ferretti,
• Anna Bujons Tur,
• Bhaskar K. Somani
Published online: October 12, 2022
p90-98

Impact of Ureteral Stent Material on Stent-related Symptoms: A Systematic Review of the Literature
• Matthias Boeykens,
• Etienne X. Keller,
• Andrea Bosio,
• ...
• Amelia Pietropaolo,
• Thomas Tailly,
• Vincent De Coninck
Published online: October 18, 2022
p108-117

Original Articles

Prostate Cancer


Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry
• Anders Bjartell,
• Luis Costa,
• Gero Kramer,
• ...
• Martin Lukac,
• Robert Wapenaar,
• Simon Chowdhury
Published online: September 17, 2022
p12-22

Reliability of Ancestry-specific Prostate Cancer Genetic Risk Score in Four Racial and Ethnic Populations
• Zhuqing Shi,
• Jianan Zhan,
• Jun Wei,
• ...
• 23andMe Research Team,
• Bertram L. Koelsch,
• Jianfeng Xu
Published online: September 17, 2022
p23-30

Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study
• Yvette Zimmerman,
• Mark Frydenberg,
• Hendrik van Poppel,
• ...
• Jan Krijgh,
• Frans M.J. Debruyne,
• Herjan J.T. Coelingh Bennink
Published online: October 03, 2022
p59-67

Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer
• Ingrid Jenny Guldvik,
• Peder Rustøen Braadland,
• Shivanthe Sivanesan,
• ...
• Wolfgang Lilleby,
• Ian G. Mills,
• Kristin Austlid Taskén
Published online: October 04, 2022
p68-75

Kidney Cancer


Impact of Partial Nephrectomy and Percutaneous Cryoablation on Short-term Health-related Quality of Life—A Prospective Comparative Cohort Study
• Theresa Junker,
• Louise Duus,
• Benjamin S.B. Rasmussen,
• ...
• Lars Lund,
• Birgitte Nørgaard,
• Ole Graumann
Published online: October 15, 2022
p99-107

Sexual Medicine


Sexual Activity and Dyspareunia After Pelvic Organ Prolapse Surgery: A 5-Year Nationwide Follow-up Study
• Olga Wihersaari,
• Päivi Karjalainen,
• Anna-Maija Tolppanen,
• Nina Mattsson,
• Kari Nieminen,
• Jyrki Jalkanen
Published online: October 12, 2022
p81-89

Education


Evidence-based Medicine: Perceptions, Attitudes, and Skills Among European Urology Residents
• Daniel A. González Padilla,
• José Daniel Subiela,
• Diego M. Carrion,
• ...
• Leonardo Tortolero-Blanco,
• Taha Uçar,
• Philipp Dahm
Published online: September 29, 2022
p44-49

Surgery in Motion: Open Science

“Light green up”: Indocyanine Green Fluorescence Imaging–guided Robotic Bilateral Inguinal Lymphadenectomy by the Hypogastric Subcutaneous Approach for Penile Cancer
• Peng Yuan,
• Kun Yao,
• Zhijiao Zhou,
• ...
• Yongxiang Tang,
• Shuo Hu,
• Long Wang
Published online: September 12, 2022
p1-7

Nightmares in Urology: Open Science

Technical Tips in Managing Large Median Lobes During Robot-assisted Radical Prostatectomy
• Vinayak G. Wagaskar,
• Osama Zaytoun,
• Priyanka Kale,
• ...
• Dallin Busby,
• Avinash Reddy,
• Ash Tewari
Published online: September 23, 2022
p32-37

Trial Protocol

Clinical Trial Protocol for PERFECT: A Randomised Controlled Trial Comparing the Efficiency and Tolerance of Transperineal Fusion Versus Transrectal Imaging-targeted Prostate Biopsies (CCAFU-PR1 Study)
• Alae Touzani,
• Gaëlle Fiard,
• Eric Barret,
• ...
• Pierre Colin,
• Morgan Rouprêt,
• Guillaume Ploussard
Published online: October 06, 2022
p76-80

Case Report

Low-energy Shockwave Therapy in the Management of Wound Healing Following Fournier’s Gangrene
• Jens J. Rassweiler,
• Walter Scheitlin,
• Ali Serdar Goezen,
• Marie-Claire Rassweiler-Seyfried
Published online: September 13, 2022
p8-11

Letters to the Editor

Reply to Julian Chavarriaga and Robert Hamilton's Letter to the Editor re: Manolis Pratsinis, Christian Fankhauser, Katerina Pratsinis, et al. Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses. Eur Urol Open Sci 2022;40:16–8. Should We Be Afraid of Surveillance? Clinically Meaningful Reasons Why Offering Surveillance for Incidentally Detected Small Testicular Masses Remains a Safe Approach
• Manolis Pratsinis,
• Christian Rothermundt,
• Christian Fankhauser
Published online: October 03, 2022
p52
Re: Manolis Pratsinis, Christian Fankhauser, Katerina Pratsinis, et al. Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses. Eur Urol Open Sci 2022;40:16–18
Should We Be Afraid of Surveillance? Clinically Meaningful Reasons Why Offering Surveillance for Incidentally Detected Small Testicular Masses Remains a Safe Approach
• Julian Chavarriaga,
• Robert Hamilton
Published online: October 01, 2022
p53-54

Corrigendum

Corrigendum re “21 – Urine exosomal miRNA profiles implicate the key role of TP53 in bladder cancer development” [Eur Urol Open Sci 2022;40(Suppl 1):S31–2]
• E. Bitina-Barlote,
• J. Plonis,
• J.K. Vasiļonoks,
• ...
• Z. Daneberga,
• E. Miklaševičs,
• M. Nakazawa-Miklaševiča
Published online: September 24, 2022
p31

Copyright page
Published in issue: November 2022
I